Get Trade Alerts

Signup for Free Email List!

Enter your Email

Preview | Powered by FeedBlitz
To subscribe to the Super Stocks Blog by RSS feeder click on :

Subscribe to: Posts (Atom)

Saturday, June 14, 2008

Time to Revisit SNT ?

I would not chase this stock, but it did approach a level on Friday that it peaked at the last time I called it. I find the agriculture side of SNT's business extremely fascinating and relevant given today's food situation. That being said I am eager to hear about any updates and/or progress on this side of the business. (Recently, the Company has been more focused on drug development - as the agriculture products are in trials with some large companies who are controlling the trials). My original entry was at $1.30 on 4/11/2008 and 11 days later it hit $1.95 for a 50% move. It subsequently sold off to the low $1's. On Friday the stock moved back to $1.91 for a 23% one day move. So I thought it would be prudent to at least review the research that had me interested in SNT in the first place and keep it on watch for further news/strength. I picked up a few shares on Friday towards the end of the day out of curiosity, knowing full well this could be a one day wonder and may be pushed down again. Otherwise, maybe it is starting getting noticed for that agriculture potential as I originally thought. Time will tell and I will watch it.

SNT Float 13.3m O/s 18.2m Bloomberg
Highlights from their website and yahoo:
Company Website
Impressive deals in place: (sample from website)

Bayer CropScience
In November 2006 we entered into an exclusive worldwide license with Bayer CropScience to commercialize our technology in Brassica oilseeds. Bayer is using the Senesco technology to enhance the yield of canola. In 2007 Bayer CropScience signed two additional licenses to commercialize our technology in Cotton and Rice.

In August 2007 we entered into an exclusive worldwide license with Monsanto to commercialize our technology in Corn and Soy. Monsanto aims to incorporate our technology into their product lines in order to enhance yield.

Cal/West Seeds
In September 2002, we entered into an exclusive development and license agreement, with Cal/West Seeds to commercialize our technology in certain varieties of alfalfa. Cal/West is the largest member-owned seed production cooperative in the United States. Alfalfa is the fourth largest crop grown in North America. Cal/West is attempting to enhance their position in the forage seed industry by enhancing seed yield, biomass and resistance to environmental stress.

In October, 2004, we entered into a license agreement with Poet, LLC to license our proprietary gene technology to Poet to improve aspects of Poet’s ethanol production capabilities. We will receive an annual payment for each Poet facility that incorporates our technology.


NEW BRUNSWICK, N.J. -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today that the Company's proprietary Factor 5A gene technology has a positive effect on plants grown in soil with low nutrient levels and in the absence of commercial fertilizer. The Senesco plants exhibited nearly three times the seed yield of unenhanced control plants under these conditions.

The Company tested its technology in Arabidopsis plants, a commonly used test plant which is closely related to the oilseed-bearing canola plant. Both Senesco's plants and the control plants were grown in low-nutrient soil with no added commercial...

Read More here
Read More here

Senesco has shown that its Factor 5A technology confers resistance to common bacterial and fungal plant diseases by preventing the induction of premature death caused by pathogens. Tests conducted both in-house and in conjunction with Senesco's lettuce development partner, the Harris Moran Seed Company, show that the development of disease symptoms caused by both fungal and bacterial pathogens is inhibited by up to 99% in plants incorporating Senesco's proprietary Factor 5A gene technology.

Read More Here

Senesco Technologies, Inc. develops technology that regulates the onset of cell death in plants. The company's technology is used to develop strains of crops without any modification other than delaying natural plant senescence
The company develops its technologies for the commercial agriculture industry, including extending the shelf life of perishable plant products, producing larger and leafier crops, increasing crop yields, and reducing the harmful effects of environmental stresses, such as drought.
One of the main advantages of our patent pending genetic technologies is their broad applicability. Our technology has shown the ability to enhance a wide variety of crops, which could be implemented by multiple licensing partners on a worldwide scale. We have already made progress to this end with our existing commercial relationships.
We are developing our technologies to address multiple opportunities within the global commercial agriculture industry, including extending the shelf life of perishable plant products, producing larger and leafier crops, increasing crop yields and reducing the harmful effects of environmental stresses, like drought.

Throughout the course of a plant’s life there are periods of productive growth and periods of dormancy. This dormancy is often in response to stresses on the plant such as diseases, pests and environmental factors. To ensure maximum productivity, commercial agriculture attempts to minimize the inefficiencies caused by these stresses. Our technology has proven useful at doing just that.

Our research has yielded substantial data to prove our theory that our patented and patent pending genes act at a critical point in the process of cell death. We have shown that by modulating the expression of these genes we can increase plant size, increase seed yield, increase shelf life of perishable produce, increase growth rates and reduce the harmful effects of a wide variety of environmental stresses.
Other technologies have been used to attempt to make commercial agriculture more efficient through biotechnology. We believe that our technology has the following inherent competitive advantages over other technologies:

• our genes are present in all plants, meaning there is no addition of foreign genetic material necessary to implement our technology;

• the activity of our technology is focused at the critical point after ripening but before senescence, meaning that taste, texture and other consumer traits which have been negatively affected by competing technologies will not be affected by the use of our technology;

• using our technology leads to a wide variety of beneficial traits;

• our technology is incorporated at the seed level, thereby avoiding the use of chemical applications to the final product, which will benefit the growers and consumers.
Shelf Life
Use of our technology has proven to be effective in extending the shelf life of perishable produce by delaying senescence. Use of our technology in carnation flowers and tomato fruit show the direct impact of reducing natural senescence, which allows the product to have a much longer viable shelf life.
Increased Biomass/Growth Rates
Overall plant size is an important trait in many commercial crops. Plants with larger leaves could be beneficial in all leafy vegetables, while trees that grow larger would certainly be more productive for the lumber and paper industries. Larger root systems allow plants to be more effective at nutrient and water uptake from the soil, thereby adding to their overall productivity.
Resistance to Environment Stress
Environmental stresses are the greatest threat to commercial agriculture. Chilling, drought, heat and soil salinity all contribute worldwide to losses of crops in the field. There is not a single crop that is immune to the negative effects of various environmental conditions. These stresses contribute directly to the kickstarting of senescence. As we have reinforced throughout our discussion of our technology, we believe that we can impart a great deal of resistance to the senescence brought about by these harmful environmental conditions.
Senesco licenses its technology to agricultural companies.


dreadknoughtY2K said...

I would love an update from them on the food science side, the food shortage scare has died down just a bit right now but with all the flooding of crops it will be in the headlines again most likely.

Anonymous said...

Hi Nice Blog .In this, the body is studied by regions rather than by organs. This is of importance to the surgeon who exposes different planes after the skin incision and who, of course, must be perfectly familiar with structures as he explores the limbs and spine anatomy cavities.

DISCLAIMER is simply a blog that has information on stocks that the author Superman, likes or may trade. The author may, and usually does have positions in some of the stocks discussed on the site or in email alerts and is under no obligation to disclose the size of the position or the time that it was acquired. The author also reserves the right to buy or sell at ANY time before during or after it is mentioned on this site or an email alert, with no notice or warnings. The posts are not at all intended to be recommendations for anyone else to buy, sell, or hold. Investors should not rely on the information given by this site to make investment decisions.

No contributor of the his site is a registered investment advisor or a broker / dealer. We DO NOT recommend whether to buy, sell, or hold securities . Although we believe the information on this site to be accurate, we DO NOT GUARANTEE the accurateness and completeness of statements made regarding stocks discussed on the site or in email alerts.

The performance section provides information to the public on selected stocks profiled by this site. Past performance should not be used as an indicator of future performances. We try the make the past performance section as accurate as possible but DO NOT GUARANTEE that the information is accurate.

This web site and all email alerts sent by this site contain "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "expects", "will," "anticipates," "estimates," believes," or statements indicating certain actions "may," "could," or "might" occur.

If any part of this disclaimer is not clear, please take the time to consult an attorney or investment specialist. Please take caution in all investment endeavors and good luck to all.

Again, My messages are not investment advice, investment solicitation or the like. Do not take action based on my messages. I do not guarantee or make claims to the accuracy of anything I post. I may buy or sell any securities I mention at anytime, even prior to posting. It is my opinion, that individuals should perform their own due diligence before investing in any stock at anytime and not base decisions on messages posted by other individuals. Individuals should assume 100% responsibility for their own investing. My messages are for my own entertainment only. LOW FLOAT stocks in particular can be volatile and are not for new traders in my opinion. I am not a registered investment advisor in any shape or form, please do not ask me for ANY investment advice.

Welcome to, blog home of Superman. Purpose of this blog is for me to discuss my trades and stock ideas (As well as opinions and rants on stock market related issues). I will mention the date and price I enter. As far as exits, I always try to take half off when I have some profit and if I believe in the stock, let the rest run further. I always also use mental stop limits, at which time I would exit and minimize any losses. I do not like to give price targets unless I can support them by P/E in some way or by comparison to another stock. I just post stock trades and ideas that I believe will go higher (or lower for shorts) and the reason I believe that. Individuals should have their own strategies for managing profits and losses. My stock picks tend to NOT be daytrades at all and many take time to move. I am not an investment advisor and this blog should not be considered or followed as investment advice.